Evidence map›Paper›PMID 39958989›Full record

ArticleFrontiers in cellular and infection microbiology2024

Mahsa Ghamari, Fereshteh Jabalameli, Shirin Afhami, Shahnaz Halimi, Mohammad Emaneini, Reza Beigverdi

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mahsa GhamariDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Fereshteh JabalameliDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Shirin AfhamiDepartment of Infectious Diseases, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Shahnaz HalimiDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad EmaneiniDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Reza BeigverdiDepartment of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic has led to the excessive use of antimicrobials in critically ill patients. Infections caused by Materials and methods: This was a cross-sectional and single-center study comprising patients with Results: The prevalence of Conclusion: The high prevalence of XDR

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsCOVID-19AdultAgedAnti-Bacterial AgentsCoinfectionCritical IllnessCross-Sectional StudiesDrug Resistance, BacterialDrug Resistance, Multiple, BacterialFemaleGenetic VariationHumansIntensive Care UnitsIranAnti-Bacterial AgentsAcinetobacter baumanniiantibiotic resistanceco-infectionglobal clonesICUREP-PCRresistance genesSARS-CoV-2

Identifiers

PMID39958989
PMCPMC11827423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.